NCT06614478 Frailty, Hip Fractures and Inflammatory Biomarkers
| NCT ID | NCT06614478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Thessaly |
| Condition | Frailty |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2027-02-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-04-01 with a primary completion date of 2027-02-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
Eligibility Criteria
Inclusion Criteria: * age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients Exclusion Criteria: * Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
Contact & Investigator
Eleni Arnaoutoglou, Professor
STUDY CHAIR
University of Thessaly
Frequently Asked Questions
Who can join the NCT06614478 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06614478 currently recruiting?
Yes, NCT06614478 is actively recruiting participants. Contact the research team at earnaout@gmail.com for enrollment information.
Where is the NCT06614478 trial being conducted?
This trial is being conducted at Larissa, Greece, Larissa, Greece.
Who is sponsoring the NCT06614478 clinical trial?
NCT06614478 is sponsored by University of Thessaly. The principal investigator is Eleni Arnaoutoglou, Professor at University of Thessaly. The trial plans to enroll 200 participants.